The pathogenesis of MALT lymphomas: Where do we stand?

Leukemia

Volumn 21, Issue 3, 2007, Pages 389-396

  Sagaert, X ^a   De Wolf Peeters, C ^a   Noels, H ^b   Baens, M ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; DOUBLE STRANDED DNA; FORKHEAD TRANSCRIPTION FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 10; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANEUPLOIDY; B CELL LYMPHOMA; BORRELIA BURGDORFERI; CAMPYLOBACTER JEJUNI; CARCINOGENESIS; CHLAMYDOPHILA PSITTACI; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 3; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; GENE ACTIVATION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC RISK; GENOTOXICITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STOMACH LYMPHOMA; STRUCTURAL CHROMOSOME ABERRATION; TUMOR LOCALIZATION;

EID: 33847187763     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404517     Document Type: Review

References (70)

1. Jaffe E, Harris N, Stein H, Vardiman J. World Health Organisation Classification of Tumours: Pathology and Genetics: Tumours of Haemopoietic and Lymphoid Tissues. IAR Press: Lyon, France, 2004, 157-161.
2. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal-zone B cells: A model of antigen-driven lymphoproliferations. Blood 2006; 107: 3034-3044.
3. Baens M, Steyls A, Dierlamm J, De Wolf-Peeters C, Marynen P. Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type. Genes Chromosomes Cancer 2000; 29: 281-291.
4. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-2339.
5. Willis TG, Jadayel DM, Du MQ, Peng HZ, Perry AR, Abdul-Rauf M et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35-45.
6. Wlodarska I, Veyt E, De Paepe P, Vandenberghe P, Nooijen P, Theate I et al. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 2005; 19: 1299-1305.
7. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 2004; 4: 348-359.
8. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al. Helicobacter pylori infection and the risk of gastric-carcinoma. N Engl J Med 1991; 325: 1127-1131.
9. Wotherspoon AC, Ortizhidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
10. Doglioni C, Wotherspoon AC, Moschini A, Deboni M, Isaacson PG. High-incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339: 834-835.
11. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-1271.
12. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid-tissue to Helicobacter-pylori. Lancet 1993; 342: 571-574.
13. Enno A, O'Rourke J, Braye S, Howlett R, Lee A. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach - effects of antimicrobial therapy on gastric MALT lymphoma in mice. Am J Pathol 1998; 152: 1625-1632.
14. Wotherspoon AC, Doglioni C, Diss TC, Pan LX, Moschini A, Deboni M et al. Regression of primary low-grade B-cell gastric lymphoma of Mucosa-associated lymphoid-tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
15. Royer B, CazalsHatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T et al. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766-775.
16. Derringer GA, Thompson LDR, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland - a clinicopathologic study of 108 cases. Am J Surg Pathol 2000; 24: 623-639.
17. Tierens A, Delabie J, Pittaluga S, Driessen A, De Wolf-Peeters C. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 1998; 91: 2381-2386.
18. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996; 10: 1190-1197.
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
20. Goossens T. Klein U, Kuppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 1998; 95: 2463-2468.
21. Sagaert X, Laurent M, Baens M, Wlodarska I, De Wolf-Peeters C. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells. Mod Pathol 2006; 19: 225-232.
22. Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722-1726.
23. Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99: 3-9.
24. Liu HX, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye HT, Molina T, Bouhnik Y et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357: 39-40.
25. Ye HT, Liu HX, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: Significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102: 1012-1018.
26. Roy N, Deveraux QL, Takahashi R, Zhou O, Ambrosini G, Altieri D et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. Blood 1997; 90: 2645.
27. Uren AG, O'Rourke K, Aravind L, Pisabarro MT, Seshagiri S, Koonin EV et al. Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000; 6: 961-967.
28. Liu HX, Hamoudi RA, Ye HT, Ruskone-Fourmestraux A, Dogan A, Isaacson PG et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol 2004; 125: 318-329.
29. Ye HT, Dogan A, Karran L, Willis TG, Chen LL, Wlodarska I et al. BCL10 expression in normal and neoplastic lymphoid tissue - nuclear localization in MALT lymphoma. Am J Pathol 2000; 157: 1147-1154.
30. Ruland J, Duncan GS, Elia A, Barrantes ID, Nguyen L, Plyte S et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κkappa B and neural tube closure. Cell 2001; 104: 33-42.
31. Xue LQ, Morris SW, Orihuela C, Tuomanen E, Cui XL, Wen RR et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1B cells. Nat Immunol 2003; 4: 857-865.
32. Lucas P, Yonezumi M, Inohara N, McAllister-Lucas L, Abazeed M, Chen F et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κkappa B signaling pathway. J Biol Chem 2001; 276: 19012-19019.
33. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;4)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 652-658.
34. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001; 61: 8820-8829.
35. Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol 2004; 25: 1495-1500.
36. Sagaert X, De Paepe P, Libbrecht L, Vanhentenrijk V, Verhoef G, Thomas J et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 2490-2497.
37. Hayden MS, Ghosh S. Signaling to NF-kappa B. Genes Dev 2004; 18: 2195-2224.
38. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF-κ B-dependent lymphocyte activation and development by paracaspase. Science 2003; 302: 1581-1584.
39. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003; 19: 749-758.
40. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κ B activation. Nat Immunol 2002; 3: 836-843.
41. Che TJ, You Y, Wang DH, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κ B activation. J Biol Chem 2004; 279: 15870-15876.
42. Sun LJ, Deng L, Ea CK, Xia ZP, Chen ZJJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004; 14: 289-301.
43. Stilo R, Liguoro D, Di JB, Formisano S, Consiglio E, Leonardi A et al. Physical and functional interaction of CARMA1 and CARMA3 with Iκ kinase gamma-NFκB essential modulator. J Biol Chem 2004; 279: 34323-34331.
44. Zhou HL, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M et al. Bcl10 activates the NF-κ B pathway through ubiquitination of NEMO. Nature 2004; 427: 167-171.
45. Hara H, Bakal C, Wada T, Bouchard D, Rottapel R, Saito T et al. The molecular adapter Carma1 controls entry of IκB kinase into the central immune synapse. J Exp Med 2004; 200: 1167-1177.
46. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation. Science 2005; 308: 114-118.
47. Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-Garcia ME, Ovechkina YL et al. Phosphorylation of the CARMA1 linker controls NF-κB activation. Immunity 2005; 23: 561-574.
48. Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B et al. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-κB activation. Immunity 2005; 23: 575-585.
49. Bidere N, Snow AL, Sakai K, Zheng L, Lenardo MJ. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-κB activation. Curr Biol 2006; 16: 1666-1671.
50. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 2005; 307: 1465-1468.
51. Zhou HL, Du MQ, Dixit VM. Constitutive NF-κ B activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 2005; 7: 425-431.
52. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83: 1243-1252.
53. Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999; 398: 533-538.
54. Varfolomeev E, Wayson SM, Dixit VM, Fairbrother WJ, Vucic D. The inhibitor of apoptosis protein fusion c-IAP2/MALT1 stimulates NF-κ B activation independently of TRAF1 and TRAF2. J Biol Chem 2006; 281: 29022-29029.
55. Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al. Selective expansion of marginal zone B cells in E mu-AP12-MALT1 mice is linked to enhanced I κ B kinase gamma polyubiquitination. Cancer Res 2006; 66: 5270-5277.
56. Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P et al. MALT1 and the AP12-MALT1 fusion act between CD40 and IKK and confer NF-κ B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005; 103: 2891-2899.
57. Hosokawa Y, Suzuki H, Suzuki Y, Takahashi R, Seto M. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res 2004; 64: 3452-3457.
58. Hu SM, Du MQ, Park SM, Alcivar A, Qu L, Gupta S et al. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest 2006; 116: 174-181.
59. Nakagawa M, Hosokawa Y, Yonezumi M, Izumiyama K, Suzuki R, Tsuzuki S et al. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. Blood 2005; 106: 4210-4216.
60. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004; 22: 3491-3497.
61. Franco R, Camacho FI, Caleo A, Staibano S, Bifano D, De RA et al. Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival. Mod Pathol 2006; 19: 1055-1067.
62. Vejabhuti C, Harris GJ, Erickson BA, Nishino H, Chevez-Barrios P, Chang CC. BCL10 expression in ocular adnexal lymphomas. Am J Ophthalmol 2005; 140: 836-843.
63. Gallardo F, Bellosillo B, Espinet B, Pujol RM, Estrach T, Servitje O et al. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma. Hum Pathol 2006; 37: 867-873.
64. Li C, Inagaki H, Kuo TT, Hu S, Okabe M, Eimoto T. Primary cutaneous marginal zone B-cell lymphoma: A molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol 2003; 27: 1061-1069.
65. Liu Y, Dong W, Chen L, Zhang P, Qi Y. Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Biochem Biophys Res Commun 2004; 320: 1-6.
66. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, Chang WC et al. A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem 2006; 281: 167-175.
67. Stoffel A, Chaurushiya M, Singh B, Levine AJ. Activation of NF-κ B and inhibition of p53-mediated apoptosis by AP12/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis. Proc Natl Acad Sci USA 2004; 101: 9079-9084.
68. Yamasaki R, Yokota K, Okada H, Hayashi S; Mizuno M, Yoshino T et al. Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma. J Med Microbiol 2004; 53: 21-29.
69. Izumiyama K, Nakagawa M, Yonezumi M, Kasugai Y, Suzuki R, Suzuki H et al. Stability and subcellular localization of AP12-MALT1 chimeric protein involved in t(11;18)(q21;q21) MALT lymphoma. Oncogene 2003; 22: 8085-8092.
70. Hosokawa Y, Suzuki H, Nakagawa M, Lee TH, Seto M. AP12-MALT1 fusion protein induces transcriptional activation of the AP12 gene through NF-κ B binding elements: Evidence for a positive feed-back loop pathway resulting in unremitting NF-κ B activation. Biochem Biophys Res Commun 2005; 334: 51-60.